Lactose intolerance but not lactose maldigestion is more frequent in patients with irritable bowel syndrome than in healthy controls

Irritable bowel syndrome (IBS) affects 10%-20% of the adult population and is characterized by abdominal symptoms without relevant organic disease. There are numerous clinical trials available investigating the relationship between IBS, lactose maldigestion (LM), and lactose intolerance (LI), but th...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Varjú Péter
Gede Noémi
Szakács Zsolt
Hegyi Péter
Cazacu Irina Mihaela
Pécsi Dániel
Fábián Anna
Szepes Zoltán
Vincze Áron
Tenk Judit
Balaskó Márta
Rumbus Zoltán
Garami András
Csupor Dezső
Czimmer József
Dokumentumtípus: Cikk
Megjelent: 2019
Sorozat:NEUROGASTROENTEROLOGY AND MOTILITY
doi:10.1111/nmo.13527

mtmt:30352599
Online Access:http://publicatio.bibl.u-szeged.hu/14307
Leíró adatok
Tartalmi kivonat:Irritable bowel syndrome (IBS) affects 10%-20% of the adult population and is characterized by abdominal symptoms without relevant organic disease. There are numerous clinical trials available investigating the relationship between IBS, lactose maldigestion (LM), and lactose intolerance (LI), but there have been no meta-analyses on this topic yet. We aimed to assess the prevalence of LM, objective and subjective (self-reported) LI in IBS patients compared to healthy controls (HC) without IBS.A systematic literature search was conducted up to 24 April 2018 in PubMed, Embase, and Cochrane Library. Adult IBS patients had to be diagnosed according to the Rome criteria or other well-defined criteria system. We enrolled controlled studies including healthy adult participants without IBS, as control group. Odds ratios with 95% confidence intervals were calculated.Altogether 14 articles were suitable for statistical analyses. IBS patients reported themselves significantly more frequently lactose intolerant than HCs (odds ratio [OR] = 3.499; 95% confidence interval [CI] = 1.622-7.551). Generally, there was no significant difference in the prevalence of LM based on ingested lactose dose (OR = 1.122; 95% CI = 0.929-1.356) and test type (OR = 1.156; 95% CI = 0.985-1.356). However, significantly more IBS patients had objective LI (OR = 2.521; 95% CI = 1.280-4.965).Lactose intolerance, but not LM is more frequent among patients with IBS compared to HCs. According to our results, IBS among other functional bowel disorders is a possible contributing factor of LI in people with LM.
Terjedelem/Fizikai jellemzők:12 p.-10.1111/nmo.13527
ISSN:1350-1925